Microbot Medical Inc (MBOT) has released an update.
Microbot Medical Inc. announced on January 18, 2024, the hiring of a US-based Clinical Research Associate to strengthen its clinical team in preparation for an Investigational Device Exemption (IDE) submission and its first human clinical trial. This follows the success of its pivotal GLP Pre-Clinical Study. The team is led by Chief Medical Officer Dr. Juan Diaz-Cartelle.
For further insights into MBOT stock, check out TipRanks’ Stock Analysis page.
